Showing results (171-180 of 188) with videos related to
Sort By:
Pageof 19
Psychopharmacology|June 5, 2008
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent modelsAnne Dekeyne, Clotilde Mannoury la Cour, Alain Gobert, et al.Autophagy|September 21, 2019
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesisPedro Barroso-Chinea, Diego Luis-Ravelo, Felipe Fumagallo-Reading, et al.The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivoMark J Millan, Per Svenningsson, Charles R Ashby, et al.EMBO Molecular Medicine|October 3, 2012
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaJulie Meffre, Séverine Chaumont-Dubel, Clotilde Mannoury la Cour, et al.The Journal of Pharmacology and Experimental Therapeutics|December 20, 2011
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterizationMark J Millan, Clotilde Mannoury la Cour, Benjamin Chanrion, et al.JAMA Psychiatry|March 12, 2020
Prevention of Psychosis: Advances in Detection, Prognosis, and InterventionPaolo Fusar-Poli, Gonzalo Salazar de Pablo, Christoph U Correll, et al.Nature Reviews. Drug Discovery|August 18, 2018
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageingBarry Boland, Wai Haung Yu, Olga Corti, et al.The Journal of Pharmacology and Experimental Therapeutics|December 20, 2011
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterizationAnne Dekeyne, Mauricette Brocco, Florence Loiseau, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 14, 2019
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)Paolo Fusar-Poli, Michael Bauer, Stefan Borgwardt, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 25, 2011
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA)Benjamin Di Cara, Roberto Maggio, Gabriella Aloisi, et al.Pageof 19